Failed primary endpoint despite Mendelian-randomization support for urate→PD; classic example of MR-justified target failing in trial.
Details
- nct_id
- NCT02642393
- phase
- phase_3
- status
- completed
- domain
- parkinsons
- indication
- Early Parkinson's Disease
- intervention
- Inosine to elevate serum urate
- sponsor
- NINDS / MJFF
- n_enrolled
- 298
- primary_endpoint
- MDS-UPDRS Parts I-III change at 24 months
Raw fields (1)
- metadata
{}